Related Experiment Video
Updated: Aug 7, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction
Matthew K Ito1, Robert L Talbert, Sotirios Tsimikas
1University of California, San Diego School of Medicine, La Jolla, California, USA.
Pharmacotherapy
|June 29, 2006
Summary
Statins offer cardiovascular benefits beyond lowering cholesterol. These drugs also improve endothelial function, stabilize plaques, and reduce inflammation and oxidative stress.
Area of Science:
- Cardiovascular Pharmacology
- Biochemistry
Background:
- Elevated serum cholesterol is a major risk factor for coronary heart disease.
- 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) primarily lower cholesterol.
- The mechanism of statin benefits in cardiovascular disease has been largely attributed to cholesterol reduction.
Purpose of the Study:
- To explore potential mechanisms of statin action beyond cholesterol reduction.
- To investigate the pleiotropic effects of statins in cardiovascular diseases.
Main Methods:
- Review of subgroup analyses from large clinical trials.
- Examination of recent experimental and clinical evidence.
Main Results:
- Evidence suggests statins have beneficial effects independent of cholesterol reduction.
- These cholesterol-independent effects include improved endothelial function.
- Statins also enhance atherosclerotic plaque stability and decrease oxidative stress and vascular inflammation.
Conclusions:
- Statins exert beneficial cardiovascular effects through mechanisms beyond lipid-lowering.
- Pleiotropic effects of statins play a significant role in managing cardiovascular diseases.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...